Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Isabelle wins cancer drug funding battle

Post Thumbnail

Health board’s U-turn to pay for drug, after pressure from The Sunday Post.

A cancer patient forced to pay thousands of pounds for a life-saving drug has won her battle for free treatment on the NHS.

Mother-of-two Isabelle McManus had been paying £3,000 a month for the drug cetuximab a medication routinely given to patients in England and Wales after her application for funding was twice rejected on cost grounds by her local health board.

The treatment fees were largely met by friends, family and work colleagues. But NHS Ayrshire and Arran has bowed to pressure and agreed to pay the future costs. They’ll also refund Isabelle the £10,000 she has already spent.

The move comes after lawyers acting for her threatened legal action.

Last night the gran, who suffers from bowel cancer, said: “I’m absolutely delighted and need to thank my family and the community. It’s been a humbling experience. People have been so generous. My colleagues at Chemring Energetics raised more than £1,000.

“We got a phone call just before Christmas confirming the NHS would fund the drug it was a wonderful present. My scan results show it has been working and the disease is static. I go to see my oncologist next week and we’ll discuss it then.”

Cetuximab can reduce or even destroy tumours in some cancer sufferers. Doctors supported Isabelle’s claim for the drug but health chiefs twice refused to fund the treatment.

The case laid bare the huge battle cancer patients in certain parts of the country face to obtain treatments which are freely available on the NHS elsewhere.

Isabelle, from Stevenston, finally started the medication in November after raising enough money to pay for it privately. Scans have since suggested the drug is working for her.

Her case for funding on the NHS was due to go to the Court of Session after solicitor Cameron Fyfe launched legal action against NHS Ayrshire and Arran. It’s believed the case would have had wide-ranging implications for other cancer patients denied drugs on the NHS.

Now in a dramatic U-turn, the health board has decided to fund her treatment and reimburse her the money she has spent.

Her brother Matt, who has been fighting her case and helping to raise funds, said: “This is fantastic news and takes the pressure off my whole family. Isabelle can now concentrate on her treatment without worrying about all the other stuff.

“I can’t thank The Sunday Post enough for fighting our corner.”

But critics slammed the health board for forcing Isabelle to go to extraordinary lengths to get the drug in the first place.

Margaret Watt, of Scotland Patients Association, said: “This is great news and a victory for common sense. The Sunday Post highlighting this case must have put the health board under a lot of pressure as would the looming legal action.

“But what is worrying is the precedent it sets. Are patients expected to cough up for treatment to prove it works or threaten court action before the NHS acts? That makes no sense.

“If Isabelle didn’t have generous friends and family she would have been denied the drug despite it working for her.”

Cameron Fyfe, of Glasgow solicitors Drummond Miller, said: “This is a great victory. The legal challenge and the Sunday Post’s intervention meant the health board had to look again at their decision.”

Mark Flannagan, of Beating Bowel Cancer, said: “This is good news. However, patients shouldn’t be forced to spend their life savings to prove that treatments will be effective before health boards decide to fund them.”

A spokeswoman for NHS Ayrshire and Arran said where there was new clinical evidence they would review the decision.